SCHEMBL3824112

SCHEMBL3824112

CCOC/C=C/c1ccc(-c2nc(-c3ccc(N(C)C)cc3)c(-c3ccc(N4CCCC4)cc3)[nH]2)cc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.60
▸ NOX1 Q9Y5S8 2/20 0.47
▸ ALOX5 P09917 2/20 0.42
▸ SELP P16109 1/20 0.39
▸ SIRT2 Q8IXJ6 2/20 0.38
▸ SIRT1 Q96EB6 2/20 0.38
▸ AURKA O14965 2/20 0.36
▸ BRAF P15056 1/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ MAPT P10636 3/20 0.35
▸ TP53 P04637 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ NSD2 O96028 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ ACHE P22303 1/20 0.34
▸ DGAT1 O75907 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL719430 0.94 ABCB1 (0.67) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL719429 0.94 ABCB1 (0.67) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL13679672 0.93 ABCB1 (0.56) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL6625154 0.90 ABCB1 (0.69) ABCB1NOX1ALOX5SIRT2SIRT1
SCHEMBL16448288 0.88 ABCB1 (0.68) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL718305 0.88 ABCB1 (0.68) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL13679697 0.86 ABCB1 (0.62) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL4442578 0.84 ABCB1 (0.53) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL4442576 0.84 ABCB1 (0.53) ABCB1NOX1ALOX5SELPSIRT2
SCHEMBL3828912 0.83 ABCB1 (0.69) ABCB1NOX1ALOX5SELPSIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0999835-B1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS TAIJI BIOMEDICAL INC (US) 2009-09-09 — — EP disclosed
EP-0999835-B1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS TAIJI BIOMEDICAL INC (US) 2009-09-09 — — EP disclosed
EP-2082740-A2 Use of imidazole derivatives as MDR modulators Taiji Biomedical, Inc. (US) 2009-07-29 — — EP disclosed
EP-2082740-A2 Use of imidazole derivatives as MDR modulators Taiji Biomedical, Inc. (US) 2009-07-29 — — EP disclosed
EP-0999835-A4 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORP (US) 2004-08-25 — — EP disclosed
EP-0999835-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS Ontogen Corporation (US) 2000-05-17 — — EP disclosed
WO-1999002155-A1 IMIDAZOLE DERIVATIVES AS MDR MODULATORS ONTOGEN CORPORATION (US) 1999-01-21 — — WO disclosed
US-5840721-A INCREASE SENSITIVITY OF MULTIDRUG RESISTANT TUMOR CELLS TO ANTICANCER AGENTS ONTOGEN CORPORATION (US) 1998-11-24 — — US disclosed
Send feedback